✦ LIBER ✦

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

✍ Scribed by Everson, Gregory T.; Sims, Karen D.; Rodriguez-Torres, Maribel; Hézode, Christophe; Lawitz, Eric; Bourlière, Marc; Loustaud-Ratti, Veronique; Rustgi, Vinod; Schwartz, Howard; Tatum, Harvey; Marcellin, Patrick; Pol, Stanislas; Thuluvath, Paul J.; Eley, Timothy; Wang, Xiaodong; Huang, Shu-Pang; McPhee, Fiona; Wind-Rotolo, Megan; Chung, Ellen; Pasquinelli, Claudio; Grasela, Dennis M.; Gardiner, David F.

Book ID: 121667120
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 608 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2013.10.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1423 INTERIM ANALYSIS OF AN INTERFERON (

1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN (RBV)-FREE REGIMEN OF DACLATASVIR (DCV), ASUNAPREVIR (ASV), AND BMS-791325 IN TREATMENT-NAIVE, HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS

✍ Everson, G.T.; Sims, K.D.; Rodriguez-Torres, M.; H'ezode, C.; Lawitz, E.; Bourli 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

763 All-Oral Therapy With Daclatasvir in

763 All-Oral Therapy With Daclatasvir in Combination With Asunaprevir and Bms-791325 for Treatment-Naive Patients With Chronic HCV Genotype 4 Infection

✍ Hassanein, Tarek; Everson, Gregory T.; Sims, Karen; Bennett, Michael T.; Gitlin, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 166 KB

P1163 ALL-ORAL THERAPY WITH DACLATASVIR

P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION

✍ Hassanein, T.; Sims, K.; Bennett, M.; Gitlin, N.; Lawitz, E.; Nguyen, T.; Webste 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P1303 AN INTERFERON- AND RIBAVIRIN-FREE

P1303 AN INTERFERON- AND RIBAVIRIN-FREE 12-WEEK REGIMEN OF ONCE-DAILY VX-135 AND DACLATASVIR IN TREATMENT-NAÏVE PATIENTS WITH GENOTYPE 1 HCV INFECTION

✍ Gane, E.; Stedman, C.; Garg, V.; George, S.; Kieffer, T.; Krop, J.; Lawal, A.; L 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 252 KB

1194 CHARACTERIZATION OF VIRAL ESCAPE IN

1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

✍ McPhee, D.; Falk, P.; Fracasso, P.; Lemm, J.; Liu, M.; Kirk, M.; Hernandez, D.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P1243 SOFOSBUVIR PLUS RIBAVIRIN, AN INTE

P1243 SOFOSBUVIR PLUS RIBAVIRIN, AN INTERFERON-FREE REGIMEN, IN THE TREATMENT OF TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC GENOTYPE 4 HCV INFECTION

✍ Ruane, P.J.; Ain, D.; Meshrekey, R.; Riad, J.; Soliman, M.; Mikhail, S.; Wolfe, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 71 KB